Notice to Readers:New Medication for Severe Malaria Available Under an Investigational New Drug Protocol

摘要

On June 21, 2007, CDCs Investiga-tional New Drug Application (IND) for intravenous artesunate went into effect. This IND allows for use of an investigational antimalarial medication (intravenous artesunate) under a protocol entitled "Intravenous Artesunate for Treatment of Severe Malaria in the United States." Intravenous artesunate can be used only under the provisions of this IND protocol because it is not a drug approved by the Food and Drug Administration (FDA).